LENSAR, Inc. (NASDAQ:LNSR) Sees Large Growth in Short Interest

LENSAR, Inc. (NASDAQ:LNSR) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 105,100 shares, an increase of 66.0% from the February 13th total of 63,300 shares. Based on an average daily volume of 93,700 shares, the days-to-cover ratio is currently 1.1 days. Currently, 1.2% of the shares of the company are short sold.

LENSAR Trading Up 3.6 %

LNSR stock traded up $0.53 on Friday, hitting $15.13. The company’s stock had a trading volume of 130,806 shares, compared to its average volume of 112,453. The firm has a 50 day moving average of $10.72 and a two-hundred day moving average of $7.78. LENSAR has a 1 year low of $2.67 and a 1 year high of $16.40. The stock has a market cap of $178.37 million, a price-to-earnings ratio of -10.36 and a beta of 0.62.

LENSAR (NASDAQ:LNSR) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40). The firm had revenue of $16.73 million during the quarter, compared to analyst estimates of $14.95 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital upped their price target on shares of LENSAR from $12.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, February 28th.

Hedge Funds Weigh In On LENSAR

Institutional investors have recently bought and sold shares of the company. Evernest Financial Advisors LLC acquired a new position in LENSAR in the 4th quarter valued at $174,000. Bailard Inc. acquired a new position in shares of LENSAR during the 4th quarter worth $181,000. Atria Investments Inc grew its stake in shares of LENSAR by 28.2% during the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company’s stock worth $233,000 after purchasing an additional 5,729 shares during the period. Essex Investment Management Co. LLC grew its stake in shares of LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company’s stock worth $357,000 after purchasing an additional 6,184 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company’s stock worth $460,000 after purchasing an additional 3,423 shares during the period. 40.15% of the stock is owned by institutional investors and hedge funds.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.